We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
While the generic drug industry expressed support for recommendations in the Bush administration’s proposed fiscal year 2008 budget that would speed up the approval process by collecting fees from manufacturers, the White House should focus on resolving key obstacles that impede bringing generic drugs to market, industry sources say.
The Indian national government last month approved the creation of an autonomous unit to regulate the import, licensing, quality and safety of pharmaceutical and medical device products.
Teva Pharmaceutical reported $460 million in earnings for the fourth quarter of 2006, reflecting a 51 percent increase from the $305 million posted in the same period a year earlier.
CVS and Caremark downplayed investor recommendations made last week calling for shareholders to reject merging the companies, a plan that could generate combined projected revenue of $75 billion.
Five countries and the Bill & Melinda Gates Foundation have committed $1.5 billion to supply children in the world’s poorest nations with new vaccines for pneumococcal disease.
GlaxoSmithKline (GSK) reported revenue of approximately $42.97 billion in 2006, up 9 percent from the year before, riding strong performances by Avandia, Lamictal and its vaccines.
While recent Centers for Disease Control and Prevention (CDC) data show an increase in the number of adolescent suicides since black box warnings were added to some types of antidepressants, there may not be enough data to link the two, a government source says.